Evidence-based medicine versus liquid-based cytology.

Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting. Obstet Gynecol (2009) 1.41

Lessons learned from successful Papanicolaou cytology cervical cancer prevention in the Socialist Republic of Vietnam. Diagn Cytopathol (2011) 0.87

Characteristics of 44 cervical cancers diagnosed following Pap-negative, high risk HPV-positive screening in routine clinical practice. Gynecol Oncol (2011) 0.86

Evidence-based medicine versus liquid based cytology. Obstet Gynecol (2008) 0.75

Liquid compared with conventional cervical cytology: a systematic review and meta-analysis. Obstet Gynecol (2008) 4.30

Update on the methods of the U.S. Preventive Services Task Force: insufficient evidence. Ann Intern Med (2009) 2.86

Screening interval and risk of invasive squamous cell cervical cancer. Obstet Gynecol (2003) 2.19

Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study. J Natl Cancer Inst (2009) 2.17

Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women. Menopause (2009) 2.07

NIH consensus development conference: diagnosing gestational diabetes mellitus. NIH Consens State Sci Statements (2013) 1.81

Association between cancer risk perception and screening behavior among diverse women. Arch Intern Med (2008) 1.70

USPSTF recommendations for STI screening. Am Fam Physician (2008) 1.68

HPV vaccination--more answers, more questions. N Engl J Med (2007) 1.64

Cervical Cancer Screening in Average-Risk Women: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med (2015) 1.63

MF101, a selective estrogen receptor beta modulator for the treatment of menopausal hot flushes: a phase II clinical trial. Menopause (2009) 1.63

Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections. PLoS One (2010) 1.55

Routine bimanual pelvic examinations: practices and beliefs of US obstetrician-gynecologists. Am J Obstet Gynecol (2012) 1.52

Reconsidering the criteria for evaluating proposed screening programs: reflections from 4 current and former members of the U.S. Preventive services task force. Epidemiol Rev (2011) 1.33

Persistent hot flushes in older postmenopausal women. Arch Intern Med (2008) 1.28

Frequency and severity of hot flashes and sleep disturbance in postmenopausal women with hot flashes. Menopause (2009) 1.23

Current cervical neoplasia screening practices of obstetrician/gynecologists in the US. Am J Obstet Gynecol (2005) 1.18

Cervical cancer screening intervals, 2006 to 2009: moving beyond annual testing. JAMA Intern Med (2013) 1.17

Ineffectiveness of sertraline for treatment of menopausal hot flushes: a randomized controlled trial. Obstet Gynecol (2007) 1.10

Willingness to use tamoxifen to prevent breast cancer among diverse women. Breast Cancer Res Treat (2012) 1.10

Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests. Obstet Gynecol (2006) 1.09

Changes in cervical cancer incidence after three decades of screening US women less than 30 years old. Obstet Gynecol (2003) 1.07

Discontinuation of postmenopausal hormone therapy. Am J Med (2005) 1.05

Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe. Sex Transm Dis (2009) 1.03

Preferences for human papillomavirus testing with routine cervical cancer screening in diverse older women. J Gen Intern Med (2008) 1.03

Pelvic examinations and access to oral hormonal contraception. Obstet Gynecol (2010) 1.01

Posttreatment human papillomavirus testing for recurrent cervical intraepithelial neoplasia: a systematic review. Am J Obstet Gynecol (2009) 0.97

Surveillance after treatment for cervical intraepithelial neoplasia: outcomes, costs, and cost-effectiveness. Obstet Gynecol (2010) 0.89

Using visual displays to communicate risk of cancer to women from diverse race/ethnic backgrounds. Patient Educ Couns (2012) 0.87

Cervical cancer screening continues to limit provision of contraception. Contraception (2005) 0.86

Defining competencies for education in health care value: recommendations from the University of California, San Francisco Center for Healthcare Value Training Initiative. Acad Med (2015) 0.86

Treatment patterns for cervical carcinoma in situ in Michigan, 1998-2003. J Registry Manag (2013) 0.81

Adding human papillomavirus testing to cytology for primary cervical cancer screening: shooting first and asking questions later. Ann Intern Med (2008) 0.81

Changes to cervical cancer prevention guidelines: effects on screening among U.S. women ages 15-29. Prev Med (2012) 0.81

Oophorectomy as a risk factor for coronary heart disease. Am J Obstet Gynecol (2008) 0.80

New guidelines: it's complicated. Obstet Gynecol (2013) 0.80

Updated recommendations for breast cancer screening. Curr Opin Obstet Gynecol (2010) 0.79

Is there an association between HIV-1 genital shedding and cervical intraepithelial neoplasia 2/3 among women on antiretroviral therapy? J Low Genit Tract Dis (2013) 0.78

Investigating Potential Associations between Cervical Procedures and HIV Acquisition. ISRN Obstet Gynecol (2011) 0.78

Trials that matter: liquid-based cervical cytology: disadvantages seem to outweigh advantages. Ann Intern Med (2007) 0.77

Receipt of cervical cancer screening in female veterans: impact of posttraumatic stress disorder and depression. Womens Health Issues (2013) 0.77

Update on quadrivalent human papillomavirus vaccination and pregnancy outcomes: is contraception advisable? Obstet Gynecol (2009) 0.75

Association of cervical biopsy with HIV type 1 genital shedding among women on highly active antiretroviral therapy. AIDS Res Hum Retroviruses (2013) 0.75

Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assay. Obstet Gynecol (2011) 0.75

Testing for human papillomavirus in women with abnormal pap smear results. JAMA (2002) 0.75

Papanicolaou testing: when does more become less? Am J Med (2005) 0.75

The new mammographic screening guidelines: what were they thinking? Obstet Gynecol (2010) 0.75

Screening pelvic examinations: right, wrong, or rite? Ann Intern Med (2014) 0.75

Cervical cancer screening among women without a cervix. JAMA (2004) 0.75

Stage at diagnosis and mortality in patients with adenocarcinoma and adenosquamous carcinoma of the uterine cervix diagnosed as a consequence of cytologic screening. Acta Cytol (2003) 0.75

Human Immunodeficiency Virus (HIV)- and Non-HIV-Associated Immunosuppression and Risk of Cervical Neoplasia. Obstet Gynecol (2017) 0.75

Effect of Replens gel used with a diaphragm on tests for human papillomavirus and other lower genital tract infections. J Low Genit Tract Dis (2006) 0.75